Prostate Specific Antigen (PSA) Testing Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Prostate specific antigen market
Prostate Specific Antigen (PSA) Testing Market: By Type (Free Prostate Specific Antigen Test, Complex Prostate Specific Antigen Test, Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test); By Assays (Radioimmunoassay, Enzyme Immunoassay); By Geography - Forecast(2018-2023)
Report Code : HCR 0038
Updated Date: 04 April, 2018  
5

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Prostate Specific Antigen Testing Market Overview
2. Prostate Specific Antigen Testing Market Executive Summary
3. PSA Testing Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. PSA Testing Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. PSA Testing Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product/Market Life Cycle Analysis
6. PSA Testing Market – By Test
   6.1. Free Prostate Specific Antigen Test
   6.2. Complex Prostate Specific Antigen Test
   6.3. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
7. PSA Testing Market – By Assays
   7.1. Radioimmunoassay (RIA)
   7.2. Enzyme Immunoassays (EIA)
8. Global PSA Testing Market - Geographic Analysis
   8.1. North America 
      8.1.1. U.S. 
      8.1.2. Canada 
      8.1.3. Mexico 
      8.1.4. Rest of North America
   8.2. South America 
      8.2.1. Brazil 
      8.2.2. Venezuela
      8.2.3. Argentina
      8.2.4. Ecuador
      8.2.5. Peru
      8.2.6. Colombia 
      8.2.7. Costa Rica
      8.2.8. Rest of South America
   8.3. Europe 
      8.3.1. U.K 
      8.3.2. Germany 
      8.3.3. Italy 
      8.3.4. France
      8.3.5. Netherlands
      8.3.6. Belgium
      8.3.7. Spain
      8.3.8. Rest of Europe
   8.4. APAC
      8.4.1. China 
      8.4.2. Australia 
      8.4.3. South Korea
      8.4.4. India
      8.4.5. Taiwan
      8.4.6. Malaysia
      8.4.7. Rest of APAC
   8.5. Middle East & Africa 
      8.5.1. Israel
      8.5.2. Saudi Arabia
      8.5.3. South Africa
      8.5.4. Rest of Middle East & Africa
   8.6. Other
9. PSA testing – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. Abbott Laboratories, Inc.
   10.2. Bayer AG
   10.3. Beckman Coulter, Inc.
   10.4. GE Healthcare
   10.5. GlaxoSmithKline, plc.
   10.6. Novartis Pharma AG
   10.7. UroLogix
   10.8. Bristol - Myers Squibb Company
   10.9. AstraZeneca plc.
   10.10. Johnson & Johnson Diagnostics
   10.11. Company 11
   10.12. Company 12
   10.13. Company 13
   10.14. Company 14
   10.15. Company 15
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Prostate-specific antigen (PSA) is a glycoprotein produced almost exclusively by the epithelial component of the prostate gland. The PSA test measures the level of PSA in blood. Small amounts of PSA are detectable in normal human blood and a serum PSA level of below 4 ng/mL is considered normal, while a level between 4 and 10 ng/mL is considered suspicious and requires repeat testing. The global prostate-specific antigen testing market is primarily progressing because of the rise in prostate cancer among men, who are over 50 years in age.

Furthermore, the adoption of various assay based methods and various new inventions for the diagnosis of prostate cancer has raised the demand for PSA testing. The combination of advanced technology for PSA testing has improved the accuracy and specificity of the results playing an important role in boosting the market. Europe contributes for a huge revenue market share for prostate specific antigen testing, accounting for nearly 45% of the global revenue.

What is Prostate Specific Antigen testing?
Prostate-specific antigen (PSA) is a type of glycoprotein secreted by epithelial prostatic cells and is a valuable tumor marker for prostate cancer. PSA liquefies semen in the seminal coagulum and allows sperm to swim freely. Elevated levels of PSA in blood serum is used to detect prostate cancer among men. Increased levels of PSA are also associated with prostatitis, an inflammation of the prostate gland. There are two forms of PSA are present in the blood. One of the form is attached to proteins while the other circulates freely. The amount of free PSA compared to the total PSA is referred to as the percent-free PSA and this is lower in men who have prostate cancer than in those without the condition. This report incorporates an in-depth assessment of PSA testing market by type, assays and geography. 



Market Research and Market Trends in Prostate Specific Antigen testing
  • A large number of biologists are working on producing monoclonal antibodies which may be useful for further development of diagnostic strategies for PSA analysis in biological materials.
  • Emergence of tests that combine measurements of PSA in blood along  with other biomarkers linked to prostate cancer in blood or urine are being studied for their ability to distinguish high-risk diseases. The other biomarkers include kallikrein-related peptidase 2, prostate cancer antigen 3 (PCA3), and the TMPRSS2-ERG gene fusion.
  • San Francisco–based Medivation discovered that androgen blockers can play a key role in battling the cancer and the company’s drug named ‘Xtandi’ has been showing significant results in extending the lives of patients in advanced stages of the disease. 
  • MDxHealth teams up with pharmaceutical company Ferrer for distribution of its SelectMDx for Prostate Cancer test in Spain. MDxHealth's molecular test offers a non-invasive cost saving 'liquid biopsy' method to assess a man's risk for prostate cancer on the basis of two biomarkers in their urine. This test would help the people in avoiding painful and invasive biopsy.

Who are the Major Players in Prostate Specific Antigen testing market?
The companies referred to in the market research report include Abbott Laboratories, Inc., Bayer AG, Beckman Coulter, Inc., GE Healthcare, GlaxoSmithKline, plc., Novartis Pharma AG, UroLogix, Bristol - Myers Squibb Company, AstraZeneca plc., Johnson & Johnson Diagnostics, BioChem Pharma, Pharmacia Delfia, Roche Diagnostics, Olympus,Tosho.

Report scope
The report incorporates in-depth assessment  the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis  so on to gauge the impact forces  potential opportunities  the market. Apart from this the report also includes a study  major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers  so on to comprehend the prevailing market dynamics at present  its impact during the forecast period 2018-2023.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase each report and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) Value ($M) data given at country level – for product types, end use applications by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT more.
  • Analyze the sales distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&A’s, deals, partnerships, and product launches all key players for the past 4 years. 
  • Evaluate the supply-dem gaps, import-export statistics regulatory Landscape for more than top 20 countries globally for the market. 
List of Tables:
Table 1: Prostate Specific Antigen (PSA) Testing Market Overview 2017-2023
Table 2: Prostate Specific Antigen (PSA) Testing Market Leader Analysis 2017-2018 (US$)
Table 3: Prostate Specific Antigen (PSA) Testing Market Product Analysis 2017-2018 (US$)
Table 4: Prostate Specific Antigen (PSA) Testing Market End User Analysis 2017-2018 (US$)
Table 5: Prostate Specific Antigen (PSA) Testing Market Patent Analysis 2013-2018* (US$)
Table 6: Prostate Specific Antigen (PSA) Testing Market Financial Analysis 2017-2018 (US$)
Table 7: Prostate Specific Antigen (PSA) Testing Market Driver Analysis 2017-2018 (US$)
Table 8: Prostate Specific Antigen (PSA) Testing Market Challenges Analysis 2017-2018 (US$)
Table 9: Prostate Specific Antigen (PSA) Testing Market Constraint Analysis 2017-2018 (US$)
Table 10: Prostate Specific Antigen (PSA) Testing Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Prostate Specific Antigen (PSA) Testing Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Prostate Specific Antigen (PSA) Testing Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Prostate Specific Antigen (PSA) Testing Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Prostate Specific Antigen (PSA) Testing Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Prostate Specific Antigen (PSA) Testing Market Value Chain Analysis 2017-2018 (US$)
Table 16: Prostate Specific Antigen (PSA) Testing Market Pricing Analysis 2018-2023 (US$)
Table 17: Prostate Specific Antigen (PSA) Testing Market Opportunities Analysis 2018-2023 (US$)
Table 18: Prostate Specific Antigen (PSA) Testing Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Prostate Specific Antigen (PSA) Testing Market Supplier Analysis 2017-2018 (US$)
Table 20: Prostate Specific Antigen (PSA) Testing Market Distributor Analysis 2017-2018 (US$)
Table 21: Prostate Specific Antigen (PSA) Testing Market Trend Analysis 2017-2018 (US$)
Table 22: Prostate Specific Antigen (PSA) Testing Market Size 2017 (US$)
Table 23: Prostate Specific Antigen (PSA) Testing Market Forecast Analysis 2018-2023 (US$)
Table 24: Prostate Specific Antigen (PSA) Testing Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 26: Prostate Specific Antigen (PSA) Testing Market By Test, Revenue & Volume, By Free Prostate Specific Antigen Test, 2018-2023 ($)
Table 27: Prostate Specific Antigen (PSA) Testing Market By Test, Revenue & Volume, By Complex Prostate Specific Antigen Test, 2018-2023 ($)
Table 28: Prostate Specific Antigen (PSA) Testing Market By Test, Revenue & Volume, By Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test, 2018-2023 ($)
Table 29: Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 30: Prostate Specific Antigen (PSA) Testing Market By Assays, Revenue & Volume, By Radioimmunoassay (RIA), 2018-2023 ($)
Table 31: Prostate Specific Antigen (PSA) Testing Market By Assays, Revenue & Volume, By Enzyme Immunoassays (EIA), 2018-2023 ($)
Table 32: North America Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 33: North America Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 34: South america Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 35: South america Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 36: Europe Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 37: Europe Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 38: APAC Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 39: APAC Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 40: Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 41: Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 42: Russia Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 43: Russia Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 44: Israel Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Test, 2018-2023 ($)
Table 45: Israel Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume, By Assays, 2018-2023 ($)
Table 46: Top Companies 2017 (US$) Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume
Table 47: Product Launch 2017-2018 Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume
Table 48: Mergers & Acquistions 2017-2018 Prostate Specific Antigen (PSA) Testing Market, Revenue & Volume

List of Figures:

Figure 1: Overview of Prostate Specific Antigen (PSA) Testing Market 2017-2023
Figure 2: Market Share Analysis for Prostate Specific Antigen (PSA) Testing Market 2017 (US$)
Figure 3: Product Comparison in Prostate Specific Antigen (PSA) Testing Market 2017-2018 (US$)
Figure 4: End User Profile for Prostate Specific Antigen (PSA) Testing Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Prostate Specific Antigen (PSA) Testing Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Prostate Specific Antigen (PSA) Testing Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Prostate Specific Antigen (PSA) Testing Market 2017-2018
Figure 8: Ecosystem Analysis in Prostate Specific Antigen (PSA) Testing Market 2017
Figure 9: Average Selling Price in Prostate Specific Antigen (PSA) Testing Market 2017-2023
Figure 10: Top Opportunites in Prostate Specific Antigen (PSA) Testing Market 2017-2018
Figure 11: Market Life Cycle Analysis in Prostate Specific Antigen (PSA) Testing Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy Test Prostate Specific Antigen (PSA) Testing Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy Assays Prostate Specific Antigen (PSA) Testing Market Revenue, 2018-2023 ($)
Figure 14: Global Prostate Specific Antigen (PSA) Testing Market - By Geography
Figure 15: Global Prostate Specific Antigen (PSA) Testing Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 16: Global Prostate Specific Antigen (PSA) Testing Market CAGR, By Geography, 2018-2023 (%)
Figure 17: North America Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 18: US Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 19: US GDP and Population, 2017-2018 ($)
Figure 20: US GDP – Composition of 2017, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2017-2018 ($)
Figure 22: Canada Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 23: Canada GDP and Population, 2017-2018 ($)
Figure 24: Canada GDP – Composition of 2017, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 26: Mexico Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 27: Mexico GDP and Population, 2017-2018 ($)
Figure 28: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 30: South America Prostate Specific Antigen (PSA) Testing Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 32: Brazil GDP and Population, 2017-2018 ($)
Figure 33: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 35: Venezuela Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 36: Venezuela GDP and Population, 2017-2018 ($)
Figure 37: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 39: Argentina Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 40: Argentina GDP and Population, 2017-2018 ($)
Figure 41: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 43: Ecuador Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 44: Ecuador GDP and Population, 2017-2018 ($)
Figure 45: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 47: Peru Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 48: Peru GDP and Population, 2017-2018 ($)
Figure 49: Peru GDP – Composition of 2017, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 51: Colombia Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 52: Colombia GDP and Population, 2017-2018 ($)
Figure 53: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 55: Costa Rica Prostate Specific Antigen (PSA) Testing Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 56: Costa Rica GDP and Population, 2017-2018 ($)
Figure 57: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 59: Europe Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 60: U.K Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 61: U.K GDP and Population, 2017-2018 ($)
Figure 62: U.K GDP – Composition of 2017, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 64: Germany Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 65: Germany GDP and Population, 2017-2018 ($)
Figure 66: Germany GDP – Composition of 2017, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 68: Italy Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 69: Italy GDP and Population, 2017-2018 ($)
Figure 70: Italy GDP – Composition of 2017, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 72: France Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 73: France GDP and Population, 2017-2018 ($)
Figure 74: France GDP – Composition of 2017, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2017-2018 ($)
Figure 76: Netherlands Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 77: Netherlands GDP and Population, 2017-2018 ($)
Figure 78: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 80: Belgium Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 81: Belgium GDP and Population, 2017-2018 ($)
Figure 82: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 84: Spain Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 85: Spain GDP and Population, 2017-2018 ($)
Figure 86: Spain GDP – Composition of 2017, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 88: Denmark Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 89: Denmark GDP and Population, 2017-2018 ($)
Figure 90: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 92: APAC Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 93: China Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023
Figure 94: China GDP and Population, 2017-2018 ($)
Figure 95: China GDP – Composition of 2017, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2017-2018 ($) Prostate Specific Antigen (PSA) Testing Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 97: Australia Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 98: Australia GDP and Population, 2017-2018 ($)
Figure 99: Australia GDP – Composition of 2017, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 101: South Korea Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 102: South Korea GDP and Population, 2017-2018 ($)
Figure 103: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 105: India Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 106: India GDP and Population, 2017-2018 ($)
Figure 107: India GDP – Composition of 2017, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2017-2018 ($)
Figure 109: Taiwan Prostate Specific Antigen (PSA) Testing Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 110: Taiwan GDP and Population, 2017-2018 ($)
Figure 111: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 113: Malaysia Prostate Specific Antigen (PSA) Testing Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 114: Malaysia GDP and Population, 2017-2018 ($)
Figure 115: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 117: Hong Kong Prostate Specific Antigen (PSA) Testing Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 118: Hong Kong GDP and Population, 2017-2018 ($)
Figure 119: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 121: Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia Prostate Specific Antigen (PSA) Testing Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123: Russia GDP and Population, 2017-2018 ($)
Figure 124: Russia GDP – Composition of 2017, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 126: Israel Prostate Specific Antigen (PSA) Testing Market Value & Volume, 2018-2023 ($)
Figure 127: Israel GDP and Population, 2017-2018 ($)
Figure 128: Israel GDP – Composition of 2017, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 130: Entropy Share, By Strategies, 2017-2018* (%) Prostate Specific Antigen (PSA) Testing Market 
Figure 131: Developments, 2017-2018* Prostate Specific Antigen (PSA) Testing Market 
Figure 132: Company 1 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 133: Company 1 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 134: Company 1 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 135: Company 2 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 136: Company 2 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 2 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 138: Company 3 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 139: Company 3 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 3 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 141: Company 4 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 142: Company 4 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 4 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 144: Company 5 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 145: Company 5 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 5 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 147: Company 6 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 148: Company 6 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 6 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 150: Company 7 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 151: Company 7 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 7 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 153: Company 8 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 154: Company 8 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 8 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 156: Company 9 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 157: Company 9 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 9 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 159: Company 10 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 160: Company 10 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 10 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 162: Company 11 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 163: Company 11 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 11 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 165: Company 12 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 166: Company 12 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 12 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 168: Company 13 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 169: Company 13 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 13 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 171: Company 14 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 172: Company 14 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 14 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 174: Company 15 Prostate Specific Antigen (PSA) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 175: Company 15 Prostate Specific Antigen (PSA) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 15 Prostate Specific Antigen (PSA) Testing Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll